ESR1 and breast carcinoma: These findings are consistent with the results of a previous MR study [15] that used an earlier version of the BCAC summary statistics [62], which reported that a 1 SD higher genetically predicted magnesium level was robustly associated with 1.17 higher odds of breast cancer and 1.2 higher odds of estrogen receptor-positive breast cancer, respectively.